Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening

Diabet Med. 2012 Jul;29(7):878-85. doi: 10.1111/j.1464-5491.2012.03637.x.

Abstract

Aims: To obtain the views of people with diabetes about the provision of diabetic retinopathy screening services; and the interval of screening.

Methods: Between October 2009 and January 2010, people with diabetes attending diabetic retinopathy screening clinics across Wales were asked to complete a questionnaire comprising of two parts: the first asking about their health, diabetes history, demographic characteristics and views about the diabetic retinopathy screening service, and the second asking about the costs of attending the screening.

Results: The response rate was 40% (n = 621) from 1550 questionnaires distributed at diabetic retinopathy clinics, with 600 complete responses analysed. Respondents had a mean known duration of diabetes of 8.5 years (sd 7.8) and had attended for screening on average 3.2 times (sd 1.6) in the last 5 years. Sixty-eight per cent (n = 408) of respondents reported having their eyes screened approximately once a year. Eighty-five per cent (n = 507) felt that they should have their eyes screened every year. However, 65% (n = 390) of respondents would accept screening at 2- or 3-year intervals if medical evidence showed that it was safe. The reported personal costs incurred by respondents attending diabetic retinopathy screening were low.

Conclusion: Our study suggests that people with diabetes undergoing diabetic retinopathy screening would accept a greater screening interval, provided that adequate clinical evidence and medical reassurance were given.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cost of Illness
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 2 / complications
  • Diabetic Retinopathy / blood
  • Diabetic Retinopathy / diagnosis*
  • Diabetic Retinopathy / economics*
  • Diabetic Retinopathy / epidemiology
  • Female
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Male
  • Mass Screening / economics
  • Mass Screening / methods
  • Middle Aged
  • Patient Preference
  • Quality of Life
  • Surveys and Questionnaires
  • Wales / epidemiology
  • Young Adult

Substances

  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human